報價延遲最少15分鐘:2025/07/21 21:21 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.32 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-8.01/--
|
|
企業價值
4.61M
|
| 資產負債 |
|
每股賬面淨值
-7.61
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
1.33M
|
|
每股收益
0.57
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/21 21:21 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders. |
